Current status of cell-based interventions in Japan

Area of Science:

• Biomedical Law
• Regulatory Science
• Regenerative Medicine

Background:

• The Act on the Safety of Regenerative Medicine governs cell-based interventions in Japan.
• Recent legal revisions necessitate the disclosure of explanatory and consent materials for therapies seeking approval.

Purpose of the Study:

• To provide an updated analysis of the current status of Japan's regenerative medicine regulatory framework.
• To identify and discuss the challenges associated with the regulatory framework for cell-based interventions.

Main Methods:

• Review of the Act on the Safety of Regenerative Medicine and its recent revisions.
• Analysis of disclosure requirements for regenerative medicine interventions.
• Assessment of the existing regulatory landscape and identified challenges.

Main Results:

• The regulatory framework requires comprehensive disclosure of patient information.
• Challenges include ensuring consistent application of disclosure standards and adapting to evolving regenerative medicine technologies.

Conclusions:

• The Japanese regulatory framework for regenerative medicine is evolving with new disclosure requirements.
• Addressing identified challenges is crucial for the effective and safe implementation of cell-based interventions in Japan.